Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.
Dec, 9 2025
Nov, 25 2025
Aug, 11 2025
Sep, 4 2023
May, 20 2026